EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification and Characterization of Novel Founder Mutations in NDRG1: Refining the Genetic Landscape of Charcot–Marie–Tooth Disease Type 4D in Bulgaria

Derek Atkinson iD, Teodora Chamova iD, Ayse Candayan iD, Kristina Kastreva, Ognian Asenov, Ivan Litvinenko, Alejandro Estrada-Cuzcano iD, Els De Vriendt iD, Georgi Kukushev, Ivailo Tournev, Albena Jordanova iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25169047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Derek Atkinson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Neurogenomics Group, VIB Center for Molecular Neurology, VIB, 2610 Antwerp, Belgium. Hauptthemen laut MEDLINE: Cell Cycle Proteins, Charcot-Marie-Tooth Disease, Founder Effect, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Antwerp, Research Foundation - Flanders, Belgian Association Against Neuromuscular Diseases (ABMM).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Charcot–Marie–Tooth neuropathy type 4D (CMT4D) is a rare genetic disorder of the peripheral nervous system caused by biallelic mutations in the N-Myc Downstream Regulated 1 gene (NDRG1). Patients present with an early onset demyelinating peripheral neuropathy causing severe distal muscle weakness and sensory loss, leading to loss of ambulation and progressive sensorineural hearing loss. The disorder was initially described in the Roma community due to a common founder mutation, and only a handful of disease-causing variants have been described in this gene so far. Here, we present genetic and clinical findings from a large Bulgarian cohort of demyelinating CMT patients harboring recurrent and novel variants in the NDRG1 gene. Notably, two splice-site variants are exclusive to Bulgarian Muslims and reside in ancestral haplotypes, suggesting a founder effect. Functional characterization of these novel variants implicates a loss-of-function mechanism due to shorter gene products. Our findings contribute to a deeper understanding of the genetic and clinical heterogeneity of CMT4D and highlight novel founder mutations in the ethnic minority of Bulgarian Muslims.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell Cycle ProteinsCharcot-Marie-Tooth DiseaseFounder EffectIntracellular Signaling Peptides and ProteinsAdolescentAdultChildFemaleHumansMaleMiddle AgedYoung AdultBulgariaHaplotypesMutationN-myc Downstream-Regulated Gene 1 Protein

Stichwörter der Autor:innen

Charcot–Marie–Tooth neuropathy type 4DNDRG1demyelinating neuropathyfounder mutationnon-Roma ethnicity

Substanzen

Cell Cycle ProteinsIntracellular Signaling Peptides and ProteinsN-myc Downstream-Regulated Gene 1 Protein

Autor:innen und Institutionen

  • Molecular Neurogenomics Group, VIB Center for Molecular Neurology, VIB, 2610 Antwerp, Belgium.
  • Department of Biomedical Sciences, University of Antwerp, 2610 Antwerp, Belgium.
  • Department of Neurology, Medical University-Sofia, 1431 Sofia, Bulgaria.
  • Department of Pediatrics, Medical University-Sofia, 1431 Sofia, Bulgaria.
  • Department of Otorhinolaryngology, Military Medical Academy-Sofia, 1606 Sofia, Bulgaria.
  • Department of Cognitive Science and Psychology, New Bulgarian University, 1618 Sofia, Bulgaria.

ORCID-Profile: Derek Atkinson, Teodora Chamova, Ayse Candayan, Alejandro Estrada-Cuzcano, Els De Vriendt, Albena Jordanova

Förderung

  • University of Antwerp
  • Research Foundation - Flanders
  • Belgian Association Against Neuromuscular Diseases (ABMM)
  • American Muscular Dystrophy Association
  • French Muscular Dystrophy Association
  • European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement
  • Bulgarian National Recovery and Resilience Plan, financed by the National Science Fund of Bulgaria (BNSF)
  • Fund for Scientific Research-Flanders

Zitieren

APA

Atkinson, D., Chamova, T., Candayan, A., Kastreva, K., Asenov, O., Litvinenko, I., Estrada-Cuzcano, A., De Vriendt, E., Kukushev, G., Tournev, I., & Jordanova, A. (2024). Identification and Characterization of Novel Founder Mutations in NDRG1: Refining the Genetic Landscape of Charcot–Marie–Tooth Disease Type 4D in Bulgaria. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25169047

Vancouver

Atkinson D, Chamova T, Candayan A, Kastreva K, Asenov O, Litvinenko I, et al. Identification and Characterization of Novel Founder Mutations in NDRG1: Refining the Genetic Landscape of Charcot–Marie–Tooth Disease Type 4D in Bulgaria. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25169047

BibTeX
@article{Atkinson2024,
  author = {Atkinson, Derek and Chamova, Teodora and Candayan, Ayse and Kastreva, Kristina and Asenov, Ognian and Litvinenko, Ivan and Estrada-Cuzcano, Alejandro and De Vriendt, Els and Kukushev, Georgi and Tournev, Ivailo and Jordanova, Albena},
  title = {Identification and Characterization of Novel Founder Mutations in NDRG1: Refining the Genetic Landscape of Charcot–Marie–Tooth Disease Type 4D in Bulgaria},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25169047}
}
Kostenlos starten →